# Pathfinder Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pathfinder-therapeutics

- Industry: Medical Devices & Equipment
- Headquarters: Nashville, US
- Website: www.pathsurg.com
- Total disclosed funding: $16M
- Latest round: Series B (Jun 18, 2013)
- Investors on record: 8

## About

Pathfinder Therapeutics, Inc. specializes in developing innovative surgical solutions and technologies, enhancing surgical procedures through advanced products aimed at improving patient outcomes and operational efficiencies for healthcare providers.Pathfinder Therapeutics, Inc. focuses on innovative surgical technology solutions to enhance medical procedures. The company was acquired by Analogic in October 2014; however, specific financial terms of the deal were not disclosed. The firm is headquartered in Nashville, US. The founder's history is not publicly available.PathSurg.com operates primarily as a domain sales platform, offering premium domain names for sale to individuals and businesses seeking to establish or enhance their online presence. The website provides a streamlined purchasing process for domains, allowing customers to either buy a domain outright or opt for a payment plan that facilitates affordable acquisition over time. The company targets a diverse clientele, including startups, established businesses, and individual entrepreneurs looking for a digital identity that resonates with their brand or personal offerings. The domains available for sale cater to various industries, with specific focus on medical and surgical themes, appealing to healthcare professionals and organizations. Geographic markets served by PathSurg.com include North America, Europe, and Asia, where demand for online presence continues to grow as businesses transition to digital platforms.The revenue model for PathSurg.com is centered around the sale of domain names, which are priced individually based on their perceived market value and demand. Customers can purchase domains directly for a flat fee or elect for a monthly payment plan, which allows payments to be divided over a specified duration. For example, a domain listed at USD 595 can be acquired through 24 monthly payments of approximately USD 24.79 each, ensuring accessibility for a wide range of buyers. The transactions are primarily B2C, where individual customers or businesses directly engage in the purchase of domain names through the website. The company offers a satisfaction guarantee, encouraging potential buyers to make purchases with confidence, thus enhancing transaction frequency and customer retention. This model stimulates revenue generation through one-time purchases while fostering long-term relationships with clients as they build their digital identities over time.Future strategies for Pathfinder Therapeutics, Inc. include the design and launch of new surgical products aimed at improving patient outcomes. The company aims to expand into additional markets, specifically targeting regions in Europe and Asia by the end of 2024. Recent funding of USD 1.240 mn raised in the Series B round will be utilized to support product development and market expansion initiatives, facilitating the enhancement of their surgical technologies.

## Funding rounds

- Series B, Jun 18, 2013, $1.2M — Hatteras Venture Partners, Mountain Group Partners, Florida Gulfshore Capital
- Series B, May 10, 2012, $5.3M — Hatteras Venture Partners
- Seed, Mar 1, 2012, $0.3M — Mountain Group Partners
- Series B, Jun 1, 2010, $4M — Clayton Associates, Hatteras Venture Partners, Tri-Star Technology, Mountain Group Partners, Florida Gulfshore Capital
- Series A, Oct 30, 2008, $5.2M — Clayton Associates, Vanderbilt University Endowment, Hatteras Venture Partners, Florida Gulfshore Capital, Nashville Capital Network, Lumira Ventures

## Investors

- Clayton Associates (https://capitalatlas.ai/funds/clayton-associates) — Series A, Series B
- Vanderbilt University Endowment — Series A
- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A, Series B
- Florida Gulfshore Capital (https://capitalatlas.ai/funds/florida-gulfshore-capital) — Series A, Series B
- Nashville Capital Network (https://capitalatlas.ai/funds/nashville-capital-network) — Series A
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series A
- Tri-Star Technology (https://capitalatlas.ai/funds/tri-star-technology) — Series B
- Mountain Group Partners (https://capitalatlas.ai/funds/mountain-group-partners) — Series B, Seed